Joining a “co-produced” walking group can be beneficial for people with Huntington’s disease, increasing their confidence, strength, and ability…
Iqra Mumal, MSc
Iqra holds a MSc in Cellular and Molecular Medicine from the University of Ottawa in Ottawa, Canada. She also holds a BSc in Life Sciences from Queen’s University in Kingston, Canada. Currently, she is completing a PhD in Laboratory Medicine and Pathobiology from the University of Toronto in Toronto, Canada. Her research has ranged from across various disease areas including Alzheimer’s disease, myelodysplastic syndrome, bleeding disorders and rare pediatric brain tumors.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Iqra Mumal, MSc
Stem cell therapy delivered via the nose led to longer lives and evidence of better circadian (internal “clock”) activity in…
A newly developed smartphone application, called the Neural Impairment Test Suite app, can run a series of tests and…
Exercise May Benefit Cardiovascular, Mitochondrial Function in Huntington’s Patients, Study Suggests
Exercise training may help improve cardiovascular and mitochondrial function in patients with Huntington’s disease, with little to no treatment-related…
A deficiency in energy metabolism in the cells of patients with Huntington’s disease can partly explain the variation in…
Huntington’s disease begins early, before birth, but symptoms tend to appear much later in life. Now, researchers working with mice…
Salivary uric acid is a valid biomarker for a wide range of potential conditions and disease states, including Huntington’s…
MMJ Files Application With FDA to Begin Clinical Trial of Cannabis-Based Meds to Treat Huntington’s
MMJ International has filed two applications with the U.S. Food and Drug Administration (FDA) requesting permission to…
Damage to Nuclear DNA Shown to Correlate with Huntington’s Duration, Patient’s Ability to Function
The level of damage present in the DNA inside the cell nucleus — called nuclear DNA — correlates with disease duration and…
Skyhawk Therapeutics and Celgene have entered into a five-year global partnership to use Skyhawk’s STAR* technology platform to discover,…